Inhibition of interleukin-1β-induced COX-2 and EP3 gene expression by sodium salicylate enhances pancreatic islet β-cell function

Diabetes

Volumn 51, Issue 6, 2002, Pages 1772-1778

  Tran, Phuong Oanh T ^a   Gleason, Catherine E ^a   Paul Robertson, R ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b PACIFIC NORTHWEST RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INTERLEUKIN 1BETA; MISOPROSTOL; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; SALICYLATE SODIUM; CYCLOOXYGENASE 2 INHIBITOR; INTERLEUKIN 1; ISOENZYME; MEMBRANE PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN EP3 RECEPTOR; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; PTGS2 PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION REGULATION; INSULIN RELEASE; MALE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; ADIPOSE TISSUE; ANIMAL; DRUG EFFECT; EPIDIDYMIS; GENETICS; HUMAN; KIDNEY; LIVER; METABOLISM; PANCREAS ISLET; PHYSIOLOGY; SECRETION; WISTAR RAT;

ADIPOSE TISSUE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; EPIDIDYMIS; GENE EXPRESSION; GLUCOSE; HUMANS; INSULIN; INTERLEUKIN-1; ISLETS OF LANGERHANS; ISOENZYMES; KIDNEY; LIVER; MALE; MEMBRANE PROTEINS; MUSCLE, SKELETAL; NF-KAPPA B; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, WISTAR; RECEPTORS, PROSTAGLANDIN E; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SODIUM SALICYLATE;

EID: 0036014899     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.6.1772     Document Type: Article

References (51)

1. Effects of prostaglandin E1 and of epinephrine on the dynamics of insulin release in vitro
2. A role for prostaglandin E in defective insulin secretion and carbohydrate intolerance in diabetes mellitus
3. Effects of prostaglandin synthesis inhibitors on human insulin secretion and carbohydrates tolerance
4. Inhibition of prostaglandin E synthesis augments glucose-induced insulin secretion in cultured pancreas
5. A role for endogenous prostaglandin E in biphasic pattern of insulin release in humans
6. Interleukin 1 is potent modulator of insulin secretion from isolated rat islets of Langerhans
7. Interleukin 1-induced prostaglandin E2: Accumulation by isolated pancreatic islets
8. Interaction of beta-cell activity and IL-1 concentration and exposure time in isolated rat islets of Langerhans
9. Interleukin-1 alpha exerts glucose-dependent stimulatory and inhibitory effects on islet cell phosphoinositide hydrolysis and insulin secretion
10. Short exposure of rat pancreatic islets to interleukin-1 beta induces a sustained but reversible impairment in beta-cell function: Influence of protease activation, gene transcription, and protein synthesis
11. Prostaglandins inhibit pancreatic beta-cell replication and long-term insulin secretion by pertussis toxin-insensitive mechanisms but do not mediate the actions of interleukin-1 beta
12. A natural interleukin 1 (IL-1) inhibitor counteracts the inhibitory effect of IL-1 on insulin production in cultured rat pancreatic islets
13. Prostaglandin E(2) mediates inhibition of insulin secretion by interleukin-1β
14. International Union of Pharmacology classification of prostanoid receptors: Properties, distribution, and structure of the receptors and their subtypes
15. Prostaglandin E receptors
16. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase
17. Inhibition of IκB kinase activity by sodium salicylate in vitro does not reflect its inhibitory mechanism in intact cells
18. Inhibition of NF-kappa B by sodium salicylate and aspirin
19. Structural determination and promoter analysis of the chicken mitogen-inducible prostaglandin G/H synthase gene and genetic mapping of the murine homolog
20. Prostanoid receptors of murine NIH 3T3 and RAW 264.7 cells: Structure and expression of the murine prostaglandin EP 4 receptor gene
21. Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate
22. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
23. Insulin secretion and cAMP metabolism in HIT cells: Reciprocal and serial passage-dependent relationships
24. Molecular regulation of prostaglandin synthesis: Implications for endocrine systems
25. TEI-3356, a highly selective agonist for the prostaglandin EP3 receptor
26. Molecular cloning and characterization of the four rat prostaglandin E2 prostanoid receptor subtypes
27. Receptor-mediated adenylate cyclase-coupled mechanism for PGE 2 inhibition of insulin secretion in HIT cells
28. Effects of prostaglandins on adenosine 3′,5′-monophosphate levels in fat and other tissues
29. Hormonal control of lipolysis in adipose tissue
30. Insulin, prostaglandin E1, phenylisopropyladenosine and nicotinic acid as regulators of fat cell metabolism
31. Antilipolytic effect of prostaglandin E2 in perifused rat adipocytes
32. Prostanoid-induced inhibition of lipolysis in rat isolated adipocytes: Probable involvement of EP3 receptors
33. Inhibition of glucagon-stimulated hepatic glycogenolysis by E-series prostaglandins
34. Pertussis toxin abolishes the inhibitory effects of prostaglandins E1, E2, I2 and F2 alpha on hormone-induced cAMP accumulation in cultured hepatocytes
35. Vasopressin-stimulated prostaglandin E biosynthesis in the toad urinary bladder: Effect of water flow
36. Apical-basolateral membrane asymmetry in canine cortical collecting tubule cells: Bradykinin, arginine vasopressin, prostaglandin E2 interrelationships
37. Regulation of cyclic AMP metabolism in rabbit cortical collecting tubule cells by prostaglandins
38. Prostaglandins as modulators of pancreatic islet function
39. Eicosanoids as pluripotential modulators of pancreatic islet function
40. The bimodal effect of interleukin 1 on rat pancreatic beta-cells - Stimulation followed by inhibition - Depends upon dose, duration of exposure, and ambient glucose concentration
41. Interleukin-1 beta depletes insulin messenger ribonucleic acid and increases the heat shock protein hsp70 in mouse pancreatic islets without impairing the glucose metabolism
42. Basal expression of cyclooxygenase-2 and nuclear factor-interleukin 6 are dominant and coordinately regulated by interleukin 1 in the pancreatic islet
43. Arachidonic acid metabolite regulation of insulin secretion
44. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs
45. Aspirin selectively inhibits prostaglandin production in human platelets
46. Modulation of insulin secretion in normal and diabetic humans by prostaglandin E and sodium salicylate
47. Restoration of the acute insulin response by sodium salicylate: A glucose dose-related phenomenon
48. Effects of aspirin on nitric oxide formation and de novo protein synthesis by RINm 5F cells and rat islets
49. Evidence for involvement of the proteasome complex (26S) and NFκB in IL-1β-induced nitric oxide and prostaglandin production by rat islets and RINm 5F cells
50. The mode of action of aspirin-like drugs: Effect on inducible nitric oxide synthase
51. Modulation of insulin secretion by cyclic AMP and prostaglandin E: The effects of theophylline, sodium salicylate and tolbutamide